National Institute on Drug Abuse; Notice of Closed Meeting

[Federal Register Volume 64, Number 36 (Wednesday, February 24, 1999)]
[Notices]
[Page 9164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-4559]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Basic Behavioral Science and Medication Development.
    Date: March 18, 1999.
    Time: 12:00 pm to 5:00 pm.
    Agenda: To review and evaluate grant applications.
    Place: Office of Extramural Program Review, National Institute 
on Drug Abuse, National Institutes of Health, 6001 Executive Blvd., 
Room 3158, Bethesda, MD 20892-9547 (Telephone Conference Call).
    Contact Person: Rita Liu, PhD, Health Scientist Administrator, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9457, Bethesda, MD 20892-9547, (301) 443-
2620.

(Catalog of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: February 18, 1999.
Anna Snouffer,
Acting Committee Management Officer, NIH.
[FR Doc. 99-4559 Filed 2-23-99; 8:45 am]
BILLING CODE 4140-01-M